Table 5 |
||
|
AS and DHA recovery after 3 months in accelerated aging conditions (40°C/75%RH) |
||
|
AS content (%) |
DHA content (%) |
|
|
|
||
|
Arsumax® |
> 95 |
3.3 |
|
|
||
|
Monolayer ASAQ tablet |
97.8 |
3.4 |
|
|
||
|
Bilayer ASAQ tablet |
99.1 |
< LOQ |
|
|
||
|
Comparison between monolayer tablets with pH regulator (batch n° 30411), bilayer high dosage tablets (batch n° 40166) and commercially available reference of AS tablets, Arsumax® |
||
|
Lacaze et al. Malaria Journal 2011 10:142 doi:10.1186/1475-2875-10-142 |
||